Phase 3 PALOMA-2 trial: I’m excited to... - SHARE Metastatic ...

SHARE Metastatic Breast Cancer

6,810 members8,426 posts

Phase 3 PALOMA-2 trial

daf10 profile image
9 Replies

I’m excited to share with you that the results from the Phase 3 PALOMA-2 trial of IBRANCE® (palbociclib) have been published in The New England Journal of Medicine. To view the Pfizer press release, click here.

pfizer.com/news/press-relea...

These data, presented at the 52nd American Society of Clinical Oncology (ASCO) Annual Meeting in June, further demonstrate the clinical benefit of IBRANCE® (palbociclib) as initial therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+, HER2-) metastatic breast cancer. The PALOMA-2 study showed the combination of IBRANCE and letrozole (Femara) extended progression-free survival (PFS), or the amount of time before tumor growth, by more than 10 months compared with letrozole plus placebo. Further, the study demonstrated that the median PFS of the IBRANCE and letrozole combination exceeded two years – making it the first and only treatment for this population of women to do so in a randomized Phase 3 study.1

Written by
daf10 profile image
daf10
To view profiles and participate in discussions please or .
Read more about...
9 Replies
marlayne profile image
marlayne

After 3 mos. on Ibrance and Femara my original tumor shrunk by 1/2 (as per the PET/CT scan). After 6 mos the cancer cells are not active. I am thrilled.

Tm7777 profile image
Tm7777 in reply tomarlayne

Awesome!!!

daf10 profile image
daf10

Fantastic news Glad to hear it I believe that others in this community will benefit from hearing your story

marlayne profile image
marlayne in reply todaf10

Thank you.

Ibelong profile image
Ibelong

Yes, thank you. That validates why my oncologist has not given up on the drug. Seems that he is fighting for me. We have only had one 3 month follow up since I began letrozole and Ibrance. That scan did not conclusively indicate any shrinkage or stabilization to the bone mets. My next pet/ct will be December. I am looking for better news then.

daf10 profile image
daf10 in reply toIbelong

Crossing my fingers for you Here's hoping for great scans.

fmlyhm0 profile image
fmlyhm0

I am on ibrance with exemestane and so far very little side effects.

Meadesmith profile image
Meadesmith

Thanks, this mirrors my experience. 19 months in, tumor shrinking, bone Mets gone.

DDIL1 profile image
DDIL1

This is an old post but checking to see how long Ibrance and Letrozole has worked for you and others?

Not what you're looking for?

You may also like...

Palbociclib and Overall Survival

Published in Metastatic Breast Cancer and Journal Scan / Research · June 30, 2022 Overall Survival...
Hazelgreen profile image

Waiting on clinical trial - currently on no treatment

Hi I’m still waiting scans & further tests etc to hopefully participate in the Emerald clinical...

IBrance alternative dosing schedule : (5 on 2 off) another trial in the works

To those who are following the news about the alternative dosing schedule (5 days on and 2 days...
Dragonfly2 profile image

Good News re: CDK4/6 Inhibitors & Overall Survival

Greetings, If you have Hormone Receptor positive, HER2 negative MBC, some great news was shared...
Bestbird profile image

Ibrance after anti-hormone drugs?

Hello, I have bone mets. Am Est+ and have cycled through Arimidex, Tamoxifen, Faslodex shots, and...
Kats3 profile image

Moderation team

See all
Jslanovich profile image
JslanovichAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.